Birlasoft Reports ₹116.1 Crore Net Profit in Q2 FY26; Revenue at ₹1,328.9 Crore

Birlasoft announced its Q2 FY26 results on November 6, reporting sequential growth in profit and revenue, supported by improved operating margins and strong deal wins.
Key Financial Highlights
- Net Profit: ₹116.1 crore, up 9.1% QoQ from ₹106.4 crore
- Revenue: ₹1,328.9 crore, up 3.4% QoQ
- EBIT: ₹193 crore, up 37.9% QoQ; margin at 14.5% vs 10.9% in Q1
- EBITDA: ₹213.3 crore, up 34.3% QoQ; margin at 16%
Cash and cash equivalents stood at ₹2,343.4 crore, up 3% sequentially and 26% YoY.
Deal Wins and Dividend
Birlasoft signed deals worth $107 million in total contract value during the quarter, including $40 million in new deals. The company also declared an interim dividend of ₹2.50 per share.
Operational Metrics
Headcount stood at 11,892 employees at the end of Q2 FY26, with attrition steady at 13.3%. Growth was driven by BFSI and Lifesciences & Services verticals, while manufacturing showed softness.
Read More: Infosys Dividend Payout Tomorrow, on November 7.
Conclusion
Birlasoft delivered improved profitability and margin expansion in Q2 FY26, supported by strong deal wins and operational efficiency. With a healthy cash position and steady attrition, the company remains focused on sustaining growth momentum in the second half of FY26.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Nov 6, 2025, 7:19 PM IST

Akshay Shivalkar
Akshay Shivalkar is a financial content specialist who strategises and creates SEO-optimised content on the stock market, mutual funds, and other investment products. With experience in fintech and mutual funds, he simplifies complex financial concepts to help investors make informed decisions through his writing.
Know More- Stocks to Watch Today: Gland Pharma, Power Grid, Rail Vikas Nigam and Others (September 4, 2026)
- Sensex Slips Below 76,100 Mark in Intraday Trade on September 7, 2026
- Stocks to Watch Today: RVNL, Cohance Lifesciences, Molbio Diagnostics and Others (September 7, 2026)
- Adani Defence Signs Five-Year Ammunition Supply Agreement for AK-203 Programme
- AstraZeneca Gains FDA Approval for Camizestrant Combo in ESR1-Mutated Advanced Breast Cancer


